KIF5B-RET Fusion Gene Identified as Potential Target in Pulmonary Adenocarcinoma

The National Cancer Center (NCC) and other research groups recently announced that they have identified KIF5B-RET (rearranged during transfection) fusion gene as a potential new target in lung cancer, suggesting that drugs which inhibit RET tyrosine kinase could prove effective...read more